Madison Muller
Stay informed with Madison Muller’s coverage and analysis.
HealthNorth Carolina drops coverage for Wegovy and Ozempic, with implications for anti-obesity drug market projected to hit $100B by 2030
By Simone Foxman, Madison Muller and BloombergJanuary 27, 2024
HealthPfizer rocked by failure of weight-loss pill set to compete with lucrative rivals Ozempic and Mounjaro
By Madison Muller and BloombergDecember 1, 2023
HealthA ‘game-changing’ study backs Wegovy use to cut heart attacks and strokes: ‘This is not just about weight and appearance’
By Madison Muller, Naomi Kresge and BloombergNovember 11, 2023
HealthFDA approves yet another weight loss drug to compete against blockbuster sellers Ozempic and Wegovy
By Madison Muller and BloombergNovember 8, 2023
HealthWeight-loss drugs like Ozempic and Wegovy come with potentially serious side effects, study finds
By Madison Muller and BloombergOctober 5, 2023
HealthWeight-loss drugs like Ozempic and Wegovy may be risky for older people because they melt away all-important muscles, experts say
By Madison Muller and BloombergSeptember 27, 2023
HealthSome weight loss pills used as alternatives to Ozempic and Wegovy contain toxic ingredients that are ‘potentially life-threatening’
By Madison Muller and BloombergSeptember 14, 2023
By Emma Court, Madison Muller and BloombergJuly 18, 2023
RetailBaby formula prices just soared to an all-time high and manufacturers are blaming it on new regulations that ‘significantly’ raise their costs
By Augusta Saraiva, Madison Muller and BloombergMay 10, 2023
HealthSeniors and people with weakened immune systems can now get a second Omicron booster as new COVID subvariants emerge
By Madison Muller, Fiona Rutherford and BloombergApril 18, 2023
By Madison Muller and BloombergDecember 31, 2022
By Madison Muller and BloombergDecember 28, 2022
By Madison Muller and BloombergNovember 1, 2022
By Madison Muller and BloombergAugust 30, 2022
By Madison Muller and BloombergAugust 16, 2022
Most Popular
